Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights

$AKBAPress releaseJul 29, 2026, 8:00 AM ETRead the release

Akebia Therapeutics announced it will release its second quarter 2026 financial results on Wednesday, August 5, 2026, following the market close. The company will host a conference call at 4:30 p.m. EDT to discuss the results and business highlights, with access available via dial-in or webcast.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.